WallStreetZenWallStreetZen

NASDAQ: MNKD
Mannkind Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MNKD

Based on 5 analysts offering 12 month price targets for Mannkind Corp

Min Forecast
$4.75+22.74%
Avg Forecast
$7.95+105.43%
Max Forecast
$10.00+158.4%

Should I buy or sell MNKD stock?

Based on 5 analysts offering ratings for Mannkind Corp.

Buy
Strong Buy
1 analysts 20%
Buy
3 analysts 60%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MNKD's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates MNKD as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their MNKD stock forecasts and price targets.

MNKD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-07
lockedlocked$00.00+00.00%2026-05-07Find Out Why
lockedlocked$00.00+00.00%2026-05-07
lockedlocked$00.00+00.00%2026-05-07
lockedlocked$00.00+00.00%2026-03-05

1 of 1

Forecast return on equity

Is MNKD forecast to generate an efficient return?

Company
-157.93%
Industry
96.54%
Market
175.71%
MNKD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MNKD forecast to generate an efficient return on assets?

Company
12.56%
Industry
27.96%
MNKD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MNKD earnings per share forecast

What is MNKD's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
-$0.00
Avg 2 year Forecast
$0.14
Avg 3 year Forecast
$0.10

MNKD revenue forecast

What is MNKD's revenue in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$471.7M+30.75%
Avg 2 year Forecast
$534.6M+48.18%
Avg 3 year Forecast
$541.7M+50.14%
MNKD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MNKD revenue growth forecast

How is MNKD forecast to perform vs Biotechnology companies and vs the US market?

Company
14.51%
Industry
33.8%
Market
13.84%
MNKD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MNKD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MNKD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MNKD$3.87$7.95+105.43%Buy
COAG$25.51$41.75+63.66%Strong Buy
XERS$6.90$10.00+44.93%Buy
AKTS$22.63$35.00+54.66%Strong Buy
MPLT$27.16$40.67+49.73%Strong Buy
View Top Biotech Stocks

Mannkind Stock Forecast FAQ

Is Mannkind Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: MNKD) stock is to Buy MNKD stock.

Out of 5 analysts, 1 (20%) are recommending MNKD as a Strong Buy, 3 (60%) are recommending MNKD as a Buy, 1 (20%) are recommending MNKD as a Hold, 0 (0%) are recommending MNKD as a Sell, and 0 (0%) are recommending MNKD as a Strong Sell.

If you're new to stock investing, here's how to buy Mannkind stock.

What is MNKD's earnings growth forecast for 2026-2028?

(NASDAQ: MNKD) Mannkind's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.02%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.54%.

Mannkind's earnings in 2026 is -$23,914,000.On average, 10 Wall Street analysts forecast MNKD's earnings for 2026 to be -$895,955, with the lowest MNKD earnings forecast at -$51,471,098, and the highest MNKD earnings forecast at $84,343,395. On average, 10 Wall Street analysts forecast MNKD's earnings for 2027 to be $43,654,658, with the lowest MNKD earnings forecast at -$21,193,981, and the highest MNKD earnings forecast at $116,783,163.

In 2028, MNKD is forecast to generate $30,616,961 in earnings, with the lowest earnings forecast at -$72,665,079 and the highest earnings forecast at $103,807,256.

What is MNKD's revenue growth forecast for 2026-2028?

(NASDAQ: MNKD) Mannkind's forecast annual revenue growth rate of 14.51% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.8%, and while it is forecast to beat the US market's average forecast revenue growth rate of 13.84%.

Mannkind's revenue in 2026 is $360,783,000.On average, 10 Wall Street analysts forecast MNKD's revenue for 2026 to be $145,734,882,804, with the lowest MNKD revenue forecast at $131,211,135,500, and the highest MNKD revenue forecast at $159,603,655,756. On average, 10 Wall Street analysts forecast MNKD's revenue for 2027 to be $165,170,937,747, with the lowest MNKD revenue forecast at $136,994,682,608, and the highest MNKD revenue forecast at $185,231,072,025.

In 2028, MNKD is forecast to generate $167,349,036,417 in revenue, with the lowest revenue forecast at $130,191,599,952 and the highest revenue forecast at $197,623,063,184.

What is MNKD's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: MNKD) forecast ROA is 12.56%, which is lower than the forecast US Biotechnology industry average of 27.96%.

What is MNKD's Price Target?

According to 5 Wall Street analysts that have issued a 1 year MNKD price target, the average MNKD price target is $7.95, with the highest MNKD stock price forecast at $10.00 and the lowest MNKD stock price forecast at $4.75.

On average, Wall Street analysts predict that Mannkind's share price could reach $7.95 by May 7, 2027. The average Mannkind stock price prediction forecasts a potential upside of 105.43% from the current MNKD share price of $3.87.

What is MNKD's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: MNKD) Mannkind's current Earnings Per Share (EPS) is -$0.07. On average, analysts forecast that MNKD's EPS will be -$0.00 for 2026, with the lowest EPS forecast at -$0.17, and the highest EPS forecast at $0.27. On average, analysts forecast that MNKD's EPS will be $0.14 for 2027, with the lowest EPS forecast at -$0.07, and the highest EPS forecast at $0.38. In 2028, MNKD's EPS is forecast to hit $0.10 (min: -$0.24, max: $0.34).

What is MNKD's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: MNKD) forecast ROE is -157.93%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.